How patients’ involvement brings quality to cancer care and policymaking

By |september 18th, 2019|breast cancer, cancer, colon cancer, manfred weber, News, Stella Kyriakides, well-being|

Medical experts and stakeholders from patient advocacy groups are keen to point out how crucial it is to consider patients’ voice as an added value when conducting cancer clinical trials, whatever policy on cancer, national or EU-wide, will eventually be put together.

Komentarji so izklopljeni za How patients’ involvement brings quality to cancer care and policymaking

Health expert: Cancer control plans must be implemented

By |september 16th, 2019|breast cancer, Cancer Plan, lung cancer, News|

The governments should take full responsibility for the implementation of national cancer plans, which are a commitment toward people and not just a piece of paper, health expert Dr Tit Albreht told EURACTIV.com in an interview.

Komentarji so izklopljeni za Health expert: Cancer control plans must be implemented

Better access to health innovation is Kyriakides’ top priority (and hardest task)

By |september 11th, 2019|breast cancer, Cancer Plan, drugs price, EFPIA, EPHA, Health Commissioner, innovation in pharmaceuticals, medicines affordability, News, Stella Kyriakides|

With increased powers, Health Commissioner-designate Stella Kyriakides is tasked with striking a difficult balance between making sure there is a steady supply of affordable medicines and ensuring that EU pharma industry remains a world leader in innov...

Komentarji so izklopljeni za Better access to health innovation is Kyriakides’ top priority (and hardest task)

Thousands of breast cancer patients can avoid chemotherapy, landmark study says

By |junij 4th, 2018|breast cancer, chemotherapy, Health, News|

Chemotherapy may be avoided in about 70% of early-stage breast cancer patients, thus limiting chemotherapy to the 30% who can be predicted it will be beneficial for them, a study released on Sunday (3 June) shows.

Komentarji so izklopljeni za Thousands of breast cancer patients can avoid chemotherapy, landmark study says

Time to address the EU’s inequalities in breast cancer diagnosis and care

By |maj 11th, 2018|breast cancer, Cristian Silviu Bușoi, News|

Across the EU, we have seen positive results for breast cancer care as more women are being diagnosed and treated earlier, leading to higher survival rates. However, while the EU as a whole is making advancement, progress is not consistent across its territory, writes Cristian Silviu Bușoi.  

Komentarji so izklopljeni za Time to address the EU’s inequalities in breast cancer diagnosis and care

MEPs step up action to protect terminally ill workers in the EU

By |maj 7th, 2018|breast cancer, cancer, diabetes, Hepatitis, News, patients|

A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.

Komentarji so izklopljeni za MEPs step up action to protect terminally ill workers in the EU

Empower cancer patients to improve quality of life, say experts

By |november 16th, 2017|breast cancer, carers, metastatic breast cancer, News, patients|

A group of metastatic breast cancer experts has urged policymakers to empower patients with greater choice and participation in their treatment and care, to improve the quality of life of patients, their carers and families.

Komentarji so izklopljeni za Empower cancer patients to improve quality of life, say experts

EU lawmakers push for better outcomes for metastatic breast cancer patients

By |oktober 18th, 2017|breast cancer, cancer, metastatic breast cancer, News, patients|

Metastatic breast cancer (MBC) kills half a million women in the EU every year, yet progress on the quality of life and survival time of MBC patients remains elusive. MEPs addressed the need to improve patient outcomes with a policy roadmap launched on...

Komentarji so izklopljeni za EU lawmakers push for better outcomes for metastatic breast cancer patients

EU agency OK’d 39 cancer drugs without evidence they work, study shows

By |oktober 5th, 2017|breast cancer, cancer, European Medicines Agency, News|

The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).

Komentarji so izklopljeni za EU agency OK’d 39 cancer drugs without evidence they work, study shows

Closing the gap on metastatic breast cancer

By |oktober 2nd, 2017|breast cancer, cancer, News|

October is breast cancer awareness month. The pink ribbon movement has achieved progress in spreading awareness and pushing for widespread cancer screening.

Komentarji so izklopljeni za Closing the gap on metastatic breast cancer